NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-01
DOI
10.1038/srep14782
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach
- (2015) Weiqiang Lu et al. Scientific Reports
- Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
- (2014) Andrea Carotti et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
- (2014) Christina Lamers et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
- (2014) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Beyond intestinal soap—bile acids in metabolic control
- (2014) Folkert Kuipers et al. Nature Reviews Endocrinology
- Characterizing ligands for farnesoid X receptor – availablein vitrotest systems for farnesoid X receptor modulator development
- (2013) Daniel Merk et al. Expert Opinion on Drug Discovery
- Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations
- (2013) Carol J. Soroka et al. MOLECULAR ASPECTS OF MEDICINE
- Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
- (2012) Ramona Steri et al. BIOCHEMICAL PHARMACOLOGY
- Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
- (2012) Daniel Merk et al. Future Medicinal Chemistry
- Role of nuclear receptor SHP in metabolism and cancer
- (2010) Yuxia Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes
- (2010) Hans G.F. Richter et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription
- (2010) Ramona Steri et al. Future Medicinal Chemistry
- Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist
- (2009) Song Feng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now